Junemann 2000.

Methods	RCT. Placebo controlled, parallel design. Double‐blind. Masking of assessors not stated. ITT analysis. Multicentre. Multinational (3).
Participants	234 patients Inclusion criteria: Urge syndrome (motor urge, sensory urge and combined motor urge and stress incontinence) verified by urodynamics.
Interventions	Group 1: trospium chloride 2 x 20mg daily (n=76) Group 2: tolterodine 2 x 2mg daily (n = 77) Group 3: placebo (n=79) 3 week treatment period. 10 day run‐in.
Outcomes	Frequency of micturition. Adverse events. Laboratory tests. Physical examinations.
Notes	Abstract. Dropouts not stated. No follow up.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Low risk	A ‐ Adequate